WallSt Focus

After setting out to disrupt the oral care category with its sonic-powered electric toothbrush and brush head refill subscription plan, the Company announced today that it is on track to expand its product lineup.

Brüush Oral Care, Inc. (NASDAQ: BRSH) is an exciting oral care-based subscription service offering sleekly designed electric toothbrushes at a competitive price. The company has grown to 38,000 subscribers and has plans to expand its products into “owning the bathroom”, making it an exciting...

OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO Pharma” or the “Company“), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases (“DED”) and ocular pain, announced the pricing of a reasonable best efforts public...

OKYO CEO Interview Gary Jacob, PHD.

DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to enrich shareholder value, today announced a letter to shareholders.

OKYO Pharma's main drug has already surpassed Phase 1 and reached Phase 2. OK-101 is catering to niches within the domain of ophthalmic diseases and is expected to see its core drug candidate in Phase 2 of clinical trials in the very near future.

Pressure BioSciences, Inc. announced that the Company’s largest shareholder has exchanged over $10 million of senior secured debt into unsecured preferred stock. The debt being converted is comprised of convertible promissory notes, accrued and unpaid interest on all promissory notes issued to...